Veysel L. Karabas
Kosekoy, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
Early visual response provides additional prognostic value beyond baseline OCT features in diabetic macular edema.
Journal: European journal of ophthalmology
Published: August 22, 2026
Real-world evaluation of anti-VEGF therapy in diabetic macular edema: The role of macular ischemia and OCT biomarkers BOSPHORUS DME study group report no: 14.
Journal: European journal of ophthalmology
Published: July 24, 2026
Correction: Real-World 6-Month Treatment Outcomes of Faricimab in Turkey: The FARTURK Study.
Journal: Ophthalmology and therapy
Published: April 04, 2026
Evaluation of anti-VEGF response in diabetic macular edema patients with baseline DRIL: a multicenter real-world study (BOSPHORUS-DME Study Group Report No.16).
Journal: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
Published: February 21, 2026
Long-term effects of adenoviral keratoconjunctivitis on conjunctival goblet cell density and tear film parameters: a prospective case-control study.
Journal: BMC ophthalmology
Published: February 21, 2026
Intravitreal Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema in Türkiye: 48-Month Data, BOSPHORUS-DME Study Group Report No. 1.
Journal: Turkish journal of ophthalmology
Published: February 18, 2026
VITRECTOMY AND SUBRETINAL tPA INJECTION FOR SUBRETINAL HEMORRHAGE SECONDARY TO RETINAL ARTERIAL MACROANEURYSM: A Multicenter Study.
Journal: Retina (Philadelphia, Pa.)
Published: February 10, 2026
Comparative Evaluation of Deep Generative Models for Predicting 12-Month Neovascular AMD Progression Using OCT and Fundus Photography.
Journal: Journal of imaging informatics in medicine
Published: February 03, 2026
Cost-effectiveness analysis of early versus late switching in treatment-naïve patients with refractory diabetic macular oedema in the Turkish population: real-world data from the Bosphorus DME study group, report number 5.
Journal: Clinical & experimental optometry
Published: January 06, 2026
Real-World 6-Month Treatment Outcomes of Faricimab in Turkey: The FARTURK Study.
Journal: Ophthalmology and therapy
Published: December 30, 2025
Real-World 6-Month Treatment Outcomes of Faricimab in Turkey: The FARTURK Study.
Journal: Ophthalmology and therapy
Published: December 30, 2025
Last Updated: 09/26/2026